Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Cancer, hepatitis treatments set for boost as China overhauls drugs list

China is set to add more than 300 new and traditional drugs to its list of medicines the state will help patients pay for, the first change in more than seven years that will boost treatments for cancer, kidney disease, hepatitis and hemophilia.

Read More »

J&J to acquire Actelion for $30 billion

Johnson & Johnson will launch an all-cash tender offer in Switzerland to acquire all of the outstanding shares of Actelion for $280 per share.

Read More »

Health insurers quietly shape Obamacare replacement with fewer risks

U.S. health insurers are making their case to Republican lawmakers over how Americans sign up for individual insurance and pushing for other changes to shape the replacement of former President Barack Obama’s national healthcare law.

Read More »

Sleep apnea screenings lack evidence: U.S. panel

It’s unclear whether everyone should be screened for a common sleep-related breathing problem, a government-backed U.S. panel says.

Read More »

Possible liver injury added to Biogen MS drug label

The prescribing label for Biogen’s big-selling oral multiple sclerosis drug Tecfidera has been updated to include a warning of potential liver injury.

Read More »

WHO seeks new leader to rebuild damaged reputation

The list of candidates to lead the World Health Organization (WHO) and rebuild its battered reputation after its slow response to West Africa’s deadly Ebola outbreak was whittled down to three, with a final choice due in May 2017.

Read More »

Study Proves Climate Impacts on Weight Loss

A new study published in Scientific Reports found Noom Coach users who lived in colder temperatures were most successful at losing weight.

Read More »

Healthcare Leaders To Congress, Administration: Improve Value-Based Care Movement

In a letter to Congress and the Administration, leading healthcare organizations called for a renewed effort to move to value-based, patient-centered payment models that reward improved quality and cost-effective care. Central to this effort is addressing the perverse incentives in the fee-for-service system, and antiquated laws and regulations that impede innovation and care coordination.

Read More »

Aurobindo Receives FDA Approval for Dalfampridine Extended-Release Tablets, 10 mg

The U.S. FDA granted final approval to Aurobindo Pharma Limited’s generic treatment for multiple sclerosis.

Read More »

Now Open for Enrollment: 2017 Healthcare Businesswomen’s Association (HBA) NY/NJ Group Mentoring Program

Registration for the 2017 HBA New York/New Jersey area Group Mentoring Program is open now through 2/28/17.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2018 Focus: Top 50 Pharma, Company of the Year and more!


Ad Right Bottom